Clinical Trials on Adult Acute Megakaryoblastic Leukemia (M7) in New Zealand
Total 920 results
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
SanofiTerminatedMyeloid LeukemiaUnited States, France, Spain
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
St. Jude Children's Research HospitalAbbVie; Gateway for Cancer Research; Karyopharm Therapeutics IncRecruitingRefractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Leukemia of Ambiguous Lineage in Relapse | Refractory Acute Leukemia of Ambiguous LineageUnited States
-
Daiichi Sankyo, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Syros PharmaceuticalsSuspendedAcute Promyelocytic LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States
-
Caribou Biosciences, Inc.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
CelgeneCompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterTakedaRecruiting
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Boehringer IngelheimTerminatedLeukemia, Myeloid, AcuteUnited States
-
Sumitomo Pharma America, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Maxinovel Pty., Ltd.RecruitingAcute Myelogenous Leukemia (AML)Australia
-
Genta IncorporatedCompleted
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
Hybrigenics CorporationUnknownAcute Myelogenous LeukemiaUnited States, France
-
Cellectis S.A.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Canada
-
CephalonCompletedAcute Myeloid LeukemiaUnited States, Canada, Australia, Germany, Israel, Italy, New Zealand, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumEnzon Pharmaceuticals, Inc.TerminatedLymphoblastic Leukemia, Acute, Childhood | Leukemia, Lymphoblastic, Acute | Lymphoblastic Leukemia, Acute | Leukemia, Lymphoblastic, Acute, T CellUnited States, Australia
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
University of RochesterRecruiting
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
Race Oncology LtdAstex Pharmaceuticals, Inc.WithdrawnAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeAustralia
-
Suhu LiuRecruitingAcute Myeloid LeukemiaUnited States
-
All India Institute of Medical Sciences, New DelhiUnknown
-
AbbVieGenentech, Inc.CompletedAML | Acute Myelogenous LeukemiaUnited States, Australia, Germany, Italy
-
St. Jude Children's Research HospitalAbbVieActive, not recruitingRefractory Acute Lymphoblastic Leukemia | Relapsed Acute Lymphoblastic LeukemiaUnited States
-
Roswell Park Cancer InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With Myelodysplasia-Related ChangesUnited States
-
Boehringer IngelheimCompletedLeukemia, Myeloid, AcuteUnited States
-
CSL LimitedParexelCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
CelgeneAbbVieCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
OncoTherapy Science, Inc.TerminatedAML | Advanced MDS | ALL | Advanced CML | Advanced MPNsUnited States
-
CelgeneApproved for marketing
-
Cornerstone PharmaceuticalsTerminatedRelapsed/Refractory Acute Myeloid LeukemiaUnited States, Spain, Korea, Republic of, France, Australia, Belgium, Austria, Germany, Poland
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myelogenous LeukemiaUnited States
-
Maxim PharmaceuticalsCompletedLeukemiaUnited States, France, Israel, Australia, Canada, Sweden, Finland, Germany, New Zealand, Denmark, Estonia, United Kingdom
-
MedImmune LLCCompletedAcute Myeloid Leukemia | LeukemiaUnited States, Israel
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Cardiff OncologyCompletedAcute Myeloid LeukemiaUnited States
-
PfizerCompletedLeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute LeukemiaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingLeukemia | Acute Lymphoblastic Leukemia | Acute Promyelocytic LeukemiaUnited States
-
Polish Adult Leukemia GroupRecruiting
-
Merus N.V.Active, not recruitingAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Italy, Netherlands, Belgium, France
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States